Interpretation of oxycodone concentrations in oral fluid

Journal of Opioid Management

Volumn 8, Issue 3, 2012, Pages 161-166

  Moore, Christine ^a   Kelley Baker, Tara ^b   Lacey, John ^b  

^a Immunalysis Corporation   (United States)

^b PACIFIC INSTITUTE FOR RESEARCH AND EVALUATION   (United States)

Author keywords

Interpretation of drug concentrations; Oral fluid; Oxycodone

Indexed keywords

OXYCODONE;

ANALGESIA; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG SALIVA LEVEL; DRUG STABILITY; DRUG URINE LEVEL; DRUG USE; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PH; RETROSPECTIVE STUDY; SALIVA ANALYSIS; SUSTAINED RELEASE FORMULATION;

ANALGESICS, OPIOID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COSTS AND COST ANALYSIS; HUMANS; INDICATORS AND REAGENTS; OXYCODONE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SALIVA; SPECIMEN HANDLING; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY;

EID: 84864767648     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2012.0112     Document Type: Article

References (20)

1. Walsh SL, Nuzzo PA, Lofwall MR, et al.: The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers. Drug Alcohol Depend. 2008; 98(3): 191-202.
2. Aquina CT, Marques-Baptista A, Bridgeman P, et al.: OxyContin abuse and overdose. Postgrad Med. 2009; 121(2): 162-167.
3. Toennes SW, Kauert GF, Steinmeyer S, et al.: Driving under the influence of drugs - evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Sci Int. 2005; 152: 149-155.
4. Reisfield GM, Salazar E, Bertholf RL: Rational use and interpretation of urine drug testing in chronic opioid therapy. Ann Clin Lab Sci. 2007; 37(4): 301-314.
5. Cone EJ, Caplan YH: Urine toxicology testing in chronic pain management. PostgradMed. 2009; 121(4): 91-102.
6. Nafziger AN, Bertino JS: Utility and application of urine drug testing in chronic pain management with opioids. Clin J Pain. 2009; 25(1): 73-79.
7. Mullangi R, Agrawal S, Srinivas NR: Measurement of xenobiotics in saliva: is saliva an attractive alternative matrix? Case studies and analytical perspectives. Biomed Chromatogr. 2009; 23(1): 3-25.
8. Drummer OH: Drug testing in oral fluid. Clin Biochem. 2006; 27: 147-159.
9. Cone EJ, Huestis MA: Interpretation of oral fluid tests for drugs of abuse. Ann N Y Acad Sci.2007; 1098: 51-103.
10. Baselt RC: Disposition of Toxic Drugs and Chemicals in Man. 8th ed. Foster City: Biomedical Publications, 2008.
11. Winek CL, Wahba WW, Winek CL Jr: Drug and chemical blood level data 2001. Forensic Sci Int. 2001; 122(2-3): 107-123.
12. Couto JE, Romney MC, Leider HL, et al.: High rates of inappropriate drug use in the chronic pain population. Popul Health Manag. 2009; 12(4): 185-190.
13. Bermejo AM, Lucas ACS, Tabernero MJ: Saliva/plasma ratio of methadone and EDDP. J Anal Toxicol. 2000; 24: 70-71.
14. Rana S, Moore C, Vincent M, et al.: Determination of propoxyphene in oral fluid, J Anal Toxicol. 2006; 30(8): 516-518.
15. Wille SM, Lillsunde P, Gunnar T, et al.: Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther Drug Monit. 2009; 31(4): 511-519.
16. Moore C, Rana S, Coulter C: Determination of meperidine, tramadol and oxycodone in human oral fluid using solid phase extraction and gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2007; 850: 370-375.
17. Ritschel WA, Parab PV, Denson DD, et al.: Absolute bioavailability of hydromorphone after peroral and rectal administration in humans: saliva/plasma ratio and clinical effects. J Clin Pharmacol. 1987; 27: 647-653.
18. Ruiz ME, Conforty P, Fagiolini P, et al.: The use of saliva as a biological fluid in relative bioavailability studies: comparison and correlation with plasma results. Biopharm Drug Dispos. 2010; 31: 476-485.
19. Hardy J, Norris R, Anderson H, et al.: Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer? Support Care Cancer. 2011 (in press). doi:10.1007/s00520-011-1147- 3.
20. Collins A, Bourland J, Backer R: Disposition of oxycodone in oral fluid. Presented at the Proceedings of the 39th Annual SOFT Conference, Oklahoma City, OK, 2009. Poster #8.